Working… Menu
Trial record 1 of 3 for:    cm24
Previous Study | Return to List | Next Study

A Study of CM24 in Combination With Nivolumab in Adults With Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04731467
Recruitment Status : Recruiting
First Posted : February 1, 2021
Last Update Posted : March 29, 2021
Bristol-Myers Squibb
Information provided by (Responsible Party):
Purple Biotech Ltd. ( Famewave Ltd. )

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : February 2024
Estimated Study Completion Date : March 2024